Cargando…
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that t...
Autores principales: | Wang, Li, Jiang, Man, Qu, Jialin, Zhou, Na, Zhang, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509820/ https://www.ncbi.nlm.nih.gov/pubmed/32983254 http://dx.doi.org/10.1186/s13027-020-00322-7 |
Ejemplares similares
-
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID‐19 epidemic
por: Zhao, Zhe, et al.
Publicado: (2020) -
Survival-associated N(6)-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
por: Qu, Jialin, et al.
Publicado: (2021) -
The challenges in colorectal cancer management during COVID-19 epidemic
por: Ren, Xianghai, et al.
Publicado: (2020) -
Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients
por: Wang, Li, et al.
Publicado: (2020) -
Effectiveness of Epidemic Preventive Policies and Hospital Strategies in Combating COVID-19 Outbreak in Taiwan
por: Tan, Ting Wan, et al.
Publicado: (2021)